tiprankstipranks
Analyst Profile
Followed by 18 other investors
.
Mitra Ramgopal

Mitra Ramgopal

Sidoti
Wall Street Analyst
Ranked #1,292 out of 8,047 Analysts on TipRanks (#2,248 out of 21,521 overall experts)

Success Rate

59%
24 out of 41 Profitable Transactions

Average Return

19.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Mitra Ramgopal's ratings since 2013 and opened each position for the duration of 1 Year:
58.54% of your transactions would have been profitable with an average return of 19.2%

Stock Rating Distribution

55Ratings
76.36% Buy
23.64% Hold
0.00% Sell
Distribution of Mitra Ramgopal's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Cantel Medical
(CMD)
Rating Type:Buy
Dates:Apr 14, 2020 - Jan 12, 2021
Gain:131.30%
The most profitable rating made by Mitra Ramgopal

Mitra Ramgopal's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
ModivCare
Hold
Initiated
0.00%
1
Bio-Reference Laboratories
Hold
Downgraded
0.00%
1
Option Care Health
Hold
Downgraded
0%
-40.80%
2
Star Equity Holdings
Buy
Initiated
$8.00
(620.79% Upside)
0%
-16.80%
1
Healthcare Services
Buy
Reiterated
$43.00
(189.76% Upside)
50%
-7.40%
2
Omnicell
Hold
Reiterated
$82.00
(-25.35% Downside)
0.00%
1
AMN Healthcare Services
Buy
Reiterated
$70.00
(-38.72% Downside)
100%
+75.23%
5
Addus Homecare
Buy
Reiterated
$140.00
(48.29% Upside)
75%
+20.85%
5
BioTelemetry
Hold
Downgraded
67%
+25.72%
7
Cantel Medical
Hold
Downgraded
75%
+38.43%
5
List of latest recommendations made by Mitra Ramgopal. Click to expand and see Mitra Ramgopal's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More